EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma

Lanting Ji, Shuang Liang, Yahsin Cheng, Ruifang Gao, Wenpeng Yan, Fang Pang, Fang Zhang

Cancer Biomarkers · 2024

DOI: 10.3233/cbm-230407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Lanting Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, …. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Mouth Neoplasms, Necroptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Necroptosis is a caspase-independent regulated necrotic cell death modality that elicits strong adaptive immune responses, and has the potential to activate antitumor immunity. Long non-coding RNAs (lncRNAs) have critical effects on oral squamous cell carcinoma (OSCC), which are closely associated with the prognosis and immune regulation of OSCC patients. OBJECTIVE: This study aimed to identify a novel necroptosis-related lncRNAs signature to predict the prognosis and immune response of OSCC patients and provide patients with anti-tumor drug selection through bioinformatics analysis and in vitro experiments. METHODS: A series of analyses, including differential lncRNA screening, survival analysis, Cox regression analysis, ROC analysis, nomogram prediction, enrichment analysis, tumor-infiltrating immune cells, drug sensitivity analysis, and consensus cluster analysis, were performed to determine and validate the prognostic value of necroptosis-associated lncRNAs signature in OSCC. And real-time quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression levels of these lncRNAs. RESULTS: This signature including 5 lncRNAs (AC099850.3, StarD4-AS1, AC011978.1, LINC01503, CDKN2A-DT) in OSCC associated with necroptosis were established and verified by bioinformatics. Further, ROC, K-M, univariate/multivariate Cox regression, and nomogram analysis were used to evaluate the model’s features for OSCC prognosis. Using multiple bioinformatics techniques, the levels of tumor-infiltrating immune cells, immune checkpoints and semi-inhibitory concentrations showed significant differences across risk subtypes. By consensus cluster analysis, there were significant differences between clusters in survival, immune checkpoint expression, clinicopathological correlation, and tumor immunity. RT-qPCR showed that AC099850.3, AC011978.1, LINC01503 were up-regulated, STARD4-AS1 and CDKN2A-DT were down-regulated in OSCC cell lines compared with human normal oral keratinoid cell line. CONCLUSION: We established 5-NRLs markers, which is useful for assessing OSCC immune response and prognosis, recommending personalized antitumor drugs. The expression level of 5-NRLs in OSCC was identified in vitro, and the results preliminarily verified this model. And this study would generate new insights for future experimental research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingMouth NeoplasmsNecroptosisHumansPrognosisBiomarkers, TumorFemaleMaleCarcinoma, Squamous CellGene Expression Regulation, NeoplasticSquamous Cell Carcinoma of Head and NeckMiddle AgedComputational Biology

Stichwörter der Autor:innen

Oral squamous cell carninomabiomarkerslncRNAsprognosisrisk model

Substanzen

RNA, Long NoncodingBiomarkers, Tumor

Autor:innen und Institutionen

  • Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, Shanxi, China.
  • Department of Physiology, School of Medicine.

Zitieren

APA

Ji, L., Liang, S., Cheng, Y., Gao, R., Yan, W., Pang, F., & Zhang, F. (2024). Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma. Cancer Biomarkers. https://doi.org/10.3233/cbm-230407

Vancouver

Ji L, Liang S, Cheng Y, Gao R, Yan W, Pang F, et al. Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma. Cancer Biomarkers. 2024. doi:10.3233/cbm-230407

BibTeX
@article{Ji2024,
  author = {Ji, Lanting and Liang, Shuang and Cheng, Yahsin and Gao, Ruifang and Yan, Wenpeng and Pang, Fang and Zhang, Fang},
  title = {Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma},
  journal = {Cancer Biomarkers},
  year = {2024},
  doi = {10.3233/cbm-230407}
}
Kostenlos starten →